Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Iscience|September 1, 2023
Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention researchBrian D Williamson, Craig A Magaret, Shelly Karuna, et al.
American Journal of Public Health|June 13, 2014
Sources of racial/ethnic differences in awareness of HIV vaccine trialsMichael P Arnold, Michele Andrasik, Stewart Landers, et al.
Plos One|December 24, 2019
Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccinationJacob A Cram, Andrew J Fiore-Gartland, Sujatha Srinivasan, et al.
Clinical Trials (London, England)|April 9, 2015
Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trialLiza Dawson, Sam Garner, Chuka Anude, et al.
Human Vaccines & Immunotherapeutics|April 24, 2018
Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trialsYunda Huang, Shelly Karuna, Lindsay N Carpp, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 18, 2022
Development of flow cytometry-based assays to assess the ability of antibodies to bind to SARS-CoV-2-infected and spike-transfected cells and mediate NK cell degranulationDieter Mielke, Sherry Stanfield-Oakley, Shalini Jha, et al.
Msphere|January 31, 2020
Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV InfectionZanele Ditse, Nonhlanhla N Mkhize, Michael Yin, et al.
Pageof 4